A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.

Trial Profile

A Prospective, Single-center, Open-label, Pilot Study to Investigate the Effect of Switching to Certican in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients.

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Dec 2015

At a glance

  • Drugs Everolimus (Primary) ; Ciclosporin; Mycophenolate mofetil; Mycophenolate sodium; Prednisone; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Adverse reactions
  • Acronyms CONCERVIC
  • Most Recent Events

    • 02 Apr 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jan 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 14 Nov 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top